At a glance
This site provides information on the independent peer review of documents defined by CDC as influential in terms of their potential impact on public policy or the private sector. CDC makes this information available to demonstrate its efforts to utilize only the most transparent and independent peer review, appropriate research methods, and the highest level of data quality.
Purpose
In addition, this information demonstrates CDC compliance with the specific requirements of the Information Quality Act (2000), 44 U.S.C. §3516, and of peer review standards developed by the Office of Management and Budget (OMB), Department of Health and Human Services (DHHS), and Centers for Disease Control and Prevention (CDC). OMB requirements, described in the Peer Review Bulletin, include making publicly available specific information on the peer review of influential documents disseminated by the federal government. OMB has defined two special categories of influential information, Influential Scientific Information (ISI) and Highly Influential Scientific Assessments (HISAs).
For issues related to the CDC/ATSDR Peer Review Agenda please contact:
Information Quality Peer Review Staff
Centers for Disease Control and Prevention
Office of Science Quality
1600 Clifton Road, NE MS D-72
Atlanta, GA 30333
The following HISAs and ISI are under development or published in final form:
Highly Influential Scientific Assessments (HISA)
NIOSH
- Draft NIOSH Criteria for a Recommended Standard: Occupational Exposure to Toluene diisocyanate
- NIOSH Criteria for a Recommended Standard: 1-Bromopropane
- NIOSH Hazard Review Wildland Fire Smoke Exposure among Farmworkers and Other Outdoor Workers
- NIOSH Skin Notation Profile for 1-Bromopropane (CAS# 106-94-5)
- NIOSH Skin Notation Profile for 2-Hydropropyl acrylate (CAS# 999-61-1)
- NIOSH Skin Notation Profile for Arsenic (CAS# 7440-38-2)
- NIOSH Skin Notation Profile for Dimethyl sulfate (CAS# 77-78-1)
- NIOSH Skin Notation Profile for Dioxathion (CAS#78-34-2)
- NIOSH Skin Notation Profile for Disulfoton (CAS# 298-04-4)
- NIOSH Skin Notation Profile for Heptachlor (CAS# 76-44-8)
- NIOSH Skin Notation Profile for Tetraethyl lead (CAS# 78-00-2)
- NIOSH Skin Notation Profile for Tetramethyl lead (CAS# 75-74-1)
- NIOSH Skin Notation Profile for Trichloroethylene (CAS# 79-01-06)
- NIOSH List of Hazardous Drugs in Healthcare Settings 2024 (formerly titled NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2024)
Toxicological
Influential Scientific Information (ISI)
- A Vapor Containment Performance Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs
- ATSDR Assessment of the Evidence for the Drinking Water Contaminants at Camp Lejeune and Specific Cancers and Other Diseases
- Best Practices for Cardiovascular Disease Prevention Programs: A Guide to Effective Health Care System Interventions and Community Programs Linked to Clinical Services
- Characterization of Departures from Regulatory Requirements Identified During Inspections Conducted by the US Federal Select Agent Program, 2014-15
- Draft NIOSH Technical Report: Approaches to Developing Occupational Exposure Limits or Bands for Engineered Nanomaterials
- Draft Skin Notation Profile: Chlorodiphenyl (42% chlorine)
- Draft Skin Notation Profile: Cyclohexanol
- Draft Skin Notation Profile: Cyclohexanone
- Draft Skin Notation Profile: Cyclonite
- Draft Skin Notation Profile: Diethylenetriamine
- Guidelines for Examining Unusual Patterns of Cancer and Environmental Concerns
- Guidelines for the use of doxycycline post-exposure prophylaxis for bacterial sexually transmitted infection prevention
- Laboratory Recommendations for Syphilis Testing in the United States
- Interaction Profile on Metallic Ions In Fracturing Waste
- NNCSS Technical Report: Prevalence of Multiple Sclerosis: Methods and Prevalence Estimates by Age, Sex, and other Demographic and Geographic Characteristics among Adults Aged 18 and Older, United States
- Update on 3HP TB Peer Review Plan
- Official American Thoracic Society / Centers for Disease Control / Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
- NNCSS Technical Report: Prevalence of Parkinson's Disease: Methods and Prevalence Estimates by Age, Sex, and other Demographic and Geographic Characteristics among Adults Aged 35 and Older, United States
- Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States - 2016
- Recommendations for Hepatitis B Screening and Testing
- Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children – United States, 2023
- Recommendations for specimen self-collection at home or in other nonclinical settings as an additional strategy for gonorrhea andchlamydia testing
- Recommendations for the Use of Specimens Collected At-Home or in Other Nonclinical Settings for Chlamydia trachomatis and Neisseria gonorrhoeae Testing
- Second National Report on Biochemical Indicators of Diet and Nutrition in the U.S. Population
- Sexually Transmitted Diseases Treatment Guidelines, 2014
- Sexually Transmitted Infections Treatment Guidelines, 2021 (cdc.gov)
- STI Treatment Guidelines (cdc.gov)
- U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
- U.S. Medical Eligibility Criteria for Contraceptive Use, 2024
- U.S. Selected Practice Recommendations for Contraceptive Use, 2016
- U.S. Selected Practice Recommendations for Contraceptive Use, 2024
Peer Review
- Peer Review Plan for Pediatric Mild Traumatic Brain Injury Guideline Report, 2017
- Peer Review Plan for Pediatric Mild Traumatic Brain Injury Guideline Report, 2016
- Peer Review Plan for the CDC Clinical Practice Guideline for Prescribing Opioids for Pain, 2022
- Peer Review Plan for the CDC Guideline for Prescribing Opioids for Chronic Pain, 2016
- Peer Review Plan for Recommendations for Hepatitis C Screening among Adults
- Peer Review Plan for Updated Recommendations for Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States - 2016
Toxicological
- Tox profile for Aldrin/Dieldrin
- Toxicological Profile for 1,1,1-Trichloroethane
- Toxicological Profile for 1,1-Dichloroethene
- Toxicological Profile for 1,2-Dichloroethane
- Toxicological Profile for 1,4-Dioxane
- Toxicological Profile for 1-Bromopropane
- Toxicological Profile for 1,2-Dichloroethane
- Toxicological Profile for 1,2-Dichloropropane
- Toxicological Profile for 1,2-Diphenylhydrazine
- Toxicological Profile for 2-Hexanone
- Toxicological Profile for 3,3'-Dichlorobenzidine
- Toxicological Profile for Acetone
- Toxicological Profile for Acrylamide
- Toxicological Profile for Antimony
- Toxicological Profile for Beryllium
- Toxicological Profile on Bromodichloromethane
- Toxicological Profile for Bromomethane
- Toxicological Profile for Butadiene
- Toxicological Profile for 2-Butanone
- Toxicological Profile for Chlorine
- Toxicological Profile for Chlorobenzene
- Toxicological Profile for Chlorodibenzofurans
- Toxicological Profile for Chloroform
- Toxicological Profile for Chloromethane
- Toxicological Profile for Chlorophenols
- Toxicological Profile for Cobalt
- Toxicological Profile for Copper
- Toxicological Profile for DDT, DDE, DDD
- Toxicological Profile for DEET (N,N-Diethyl-meta-toluamide)
- Toxicological Profile for Di(2-ethylhexyl) phthalate
- Toxicological Profile for Dinitrophenols
- Toxicological Profile for Dinitrotoluenes
- Toxicological Profile for Disulfoton
- Toxicological Profile for Endosulfan
- Toxicological Profile for Endrin
- Toxicological Profile for Ethyl Benzene
- Toxicological Profile for Ethylene Glycol
- Toxicological Profile for Ethylene Oxide
- Toxicological Profile for Glutaraldehyde
- Toxicological Profile for Glyphosate
- Toxicological Profile for Hexachlorobenzene
- Toxicological Profile for Hexachlorobutadiene
- Toxicological Profile for Hexachlorocyclohexanes
- Toxicological Profile for Hydrogen Sulfide and Carbonyl Sulfide
- Toxicological Profile for Jet fuels
- Toxicological Profile for Lead
- Toxicological Profile for Mercury
- Toxicological Profile for Methyl tert-Butyl Ether (MTBE)
- Toxicological Profile for Mirex and Chlordecone
- Toxicological Profile for Molybdenum
- Toxicological Profile for Nitrate and Nitrite
- Toxicological Profile for Nitrobenzene
- Toxicological Profile for Nitrophenols
- Toxicological Profile for N-nitrosodi-n-propylamine
- Toxicological Profile for N-Nitrosodimethylamine
- Toxicological Profile for Parathion
- Toxicological profile for Pentachlorophenol
- Toxicological Profile for Perfluoroalkyls
- Toxicological Profile for Phosphate esters
- Toxicological Profile for Polybrominated Diphenyl Ethers (PBDE)
- Toxicological Profile for RDX
- Toxicological Profile for Silica
- Toxicological Profile for Styrene
- Toxicological Profile for Tetrachloroethylene (PERC)
- Toxicological Profile for Toluene
- Toxicological Profile for Toluene Diisocyanate
- Toxicological Profile for Toxaphene
- Toxicological Profile for Tribufos
- Toxicological Profile for Trichlorobenzenes
- Toxicological Profile for Trichloroethylene (TCE)
- Toxicological Profile for 1,1,1-Trichloroethane
- Toxicological Profile for 1,2,3-Trichloropropane
- Toxicological Profile for Uranium
- Toxicological Profile for Vinyl Chloride